These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2601000)
41. Digitoxin antibody cross-reactivity and evaluation of potential candidates for circulating digitalis-like immunoreactive factor. Graves SW; Naomi S; Williams GH; Hollenberg NK Clin Chem; 1994 Oct; 40(10):1977-8. PubMed ID: 7923784 [No Abstract] [Full Text] [Related]
42. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors. Graves SW; Sharma K; Chandler AB Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385 [TBL] [Abstract][Full Text] [Related]
43. Atrial natriuretic factor, digoxin-like immunoreactive substance, norepinephrine, epinephrine, and plasma renin activity in human fetuses and their alteration by fetal disease. Weiner CP; Robillard JE Am J Obstet Gynecol; 1988 Dec; 159(6):1353-60. PubMed ID: 2974684 [TBL] [Abstract][Full Text] [Related]
44. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay. Smith RL Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591 [No Abstract] [Full Text] [Related]
45. Malignant immunoblastic lymphoma complicated by IgM gammopathy and digoxin-like immunoreactive substance. Ng JP; Green ST; McGovern E; Horn EM; Whiting B; Cumming RL; Hogg RB Clin Lab Haematol; 1987; 9(4):421-3. PubMed ID: 3442977 [No Abstract] [Full Text] [Related]
46. Pharmacological actions of "kyushin," a drug containing toad venom (3): Effects on experimentally induced arrhythmia. Morishita S; Sugimoto C; Shoji M; Hirai Y; Oguni Y; Ito C; Higuchi M; Sakanashi M Am J Chin Med; 1993; 21(2):139-49. PubMed ID: 8237891 [TBL] [Abstract][Full Text] [Related]
47. Digoxin-like immunoreactive substance in renal failure: a reappraisal. Greenway DC; Nanji AA Nephron; 1986; 44(2):108-10. PubMed ID: 3774074 [TBL] [Abstract][Full Text] [Related]
54. Endogenous digoxin-like factor contributes to the elevation of systemic resistance in rats exposed to high salt intake from prepuberty. Zicha J; Kunes J; Stolba P J Hypertens Suppl; 1985 Dec; 3(3):S17-9. PubMed ID: 2856698 [TBL] [Abstract][Full Text] [Related]
55. [Changes in plasma and urinary digoxin-immunoreactive like substance in normal pregnancy and pregnancy-induced hypertensive women]. Li AQ; Zhang ZJ Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):133-5, 187. PubMed ID: 8354089 [TBL] [Abstract][Full Text] [Related]
56. [Studies on serum digoxin levels under administration of the Kyushin]. Fushimi R; Tsujimura K; Yasuhara M; Iyama S; Kou T; Motoi S; Khoda K; Hayashi C; Tachi J; Amino N Rinsho Byori; 1988 Sep; 36(9):1090-4. PubMed ID: 3246744 [No Abstract] [Full Text] [Related]
57. Effect of storage temperature on concentrations of digoxin-like immunoreactive factor(s) in plasma. Krivoy N; Jakobi P Clin Chem; 1989 May; 35(5):895-6. PubMed ID: 2720993 [No Abstract] [Full Text] [Related]
59. Digoxin-like immunoreactivity, endogenous cardiac glycoside-like factor(s) and natriuretic hormone: more than a hypothesis. Clerico A J Nucl Med Allied Sci; 1987; 31(4):341-56. PubMed ID: 2832557 [No Abstract] [Full Text] [Related]
60. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale]. Shi YS; Liu JH; Yu XZ Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]